Skip to content
Independent analysis of NHS open data
PharmaInsight

Tapentadol 250mg modified-release tablets

0407020AGAAAGAG · Central Nervous System
Data updated May 2026
350items

Dispensed in May 2026

NHSBSA Prescription Cost Analysis

£33,602

Net ingredient cost · May 2026

NHSBSA PCA

4,273items

Dispensed in the last 12 months

NHSBSA PCA

Figure 1. Tapentadol 250mg modified-release tablets: national items dispensed by month

0 248.5 497 Jun 2021 Dec 2021 Apr 2024 Oct 2024 Apr 2025 Oct 2025 May 2026 350 Jun 2021: 497 Jul 2021: 481 Aug 2021: 465 Sep 2021: 471 Oct 2021: 429 Nov 2021: 458 Dec 2021: 467 Jan 2022: 411 Feb 2022: 412 Mar 2022: 453 Apr 2022: 408 May 2022: 446 Apr 2024: 414 May 2024: 430 Jun 2024: 380 Jul 2024: 418 Aug 2024: 397 Sep 2024: 388 Oct 2024: 420 Nov 2024: 396 Dec 2024: 436 Jan 2025: 414 Feb 2025: 383 Mar 2025: 394 Apr 2025: 378 May 2025: 390 Jun 2025: 375 Jul 2025: 377 Aug 2025: 361 Sep 2025: 372 Oct 2025: 370 Nov 2025: 345 Dec 2025: 373 Jan 2026: 356 Feb 2026: 307 Mar 2026: 344 Apr 2026: 343 May 2026: 350

Source: NHSBSA Prescription Cost Analysis, to May 2026

One presentation of Tapentadol. See the chemical for the full national picture and related presentations.

Top dispensing practices

Dispensing GP practices supplying this presentation, by items (a subset of national dispensing).